Last updated on October 2018

Optilene Suture for Coronary Artery Bypass Graft Surgery

Brief description of study

The study is a voluntary study, initiated by B. Braun to collect clinical data for Optilene suture concerning its key indication.

Detailed Study Description

Coronary artery bypass graft (CABG) surgery is one of the most common elective surgical procedure. In total 40.000 CABGs have been performed yearly in Germany in 2012 and 2013 which presents 60% of all cardiac surgical interventions. Coronary artery bypass grafting is performed for patients with coronary artery disease (CAD) to improve quality of life and to reduce cardiac-related mortality. CAD is the most leading cause of mortality in the Western world as well as in developing countries and it is the most common cause of heart failure. CABG was introduced in the 1960s. CABG operation has become the most studied intervention in the history of surgery. It is highly effective in the treatment of severe angina and it delays unfavorable events such as death, myocardial infarction and recurrence of angina in comparison to other treatment forms. There is a general agreement that already in the early postoperative period CABG surgery improves the disease in patients with symptomatic left main coronary artery stenosis or stenosis of the three main coronary vessels.

Clinical Study Identifier: NCT02546557

Contact Investigators or Research Sites near you

Start Over

Petra Baumann, Dr.

Robert Bosch KH Stuttgart
Stuttgart, Germany

Petra Baumann, Dr.

Sacco Hospital
Milano, Italy

Angelo L Nobre, Prof. Dr.

Hospital de Santa Maria
Lisboa, Portugal

Petra Baumann, Dr.

Hospital de la Santa Creu I Sant Pau
Barcelona, Spain